| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.00036 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |